Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,462 | -991 | -714 | N/A | N/A |
| Depreciation Amortization | 1 | 5 | N/A | N/A | N/A |
| Accounts receivable | 735 | -735 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -696 | 969 | -3 | N/A | N/A |
| Other Working Capital | -401 | 422 | 78 | N/A | N/A |
| Other Operating Activity | 1,852 | -146 | 80 | 0 | 0 |
| Operating Cash Flow | $-3,971 | $-477 | $-559 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 530 | N/A | N/A | N/A |
| Common Stock Issued | 12,044 | N/A | 3 | N/A | N/A |
| Other Financing Activity | 0 | -87 | 244 | 0 | 0 |
| Financing Cash Flow | $12,044 | $443 | $246 | $N/A | $N/A |
| Beginning Cash Position | 2 | 35 | 348 | N/A | N/A |
| End Cash Position | 8,075 | 2 | 35 | N/A | N/A |
| Net Cash Flow | $8,073 | $-34 | $-312 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,971 | -477 | -559 | N/A | N/A |
| Free Cash Flow | -3,971 | -477 | -559 | 0 | 0 |